To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers

Clinical trial NCT06821698 · COMPLETED

Trial details

NCT number: NCT06821698
Sponsor: Kaken Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healty Volunteers

Start date: 2025-02-13
Primary completion: 2025-05-20
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.